Cancer Center Oncology Medical Group

La Mesa, California 91942

0 studies enrolling now · 9 studies all time

What they study most

Advanced Prostate Cancer, Blood Clot, Cancer, Castration-Resistant Prostate Cancer, Castration-resistant Prostate Cancer, Deep Vein Thrombosis (DVT), Hormone Refractory Prostate Cancer, Ovarian Neoplasms, Prostate Cancer, Prostate Cancer Metastatic, Prostatic Neoplasms, Pulmonary Embolism (PE)

Studies at this site

• Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC — Running, not enrolling
• Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer — Completed
• A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer — Completed
• A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer — Completed
• Concurrent vs. Sequential Sipuleucel-T & Abiraterone Treatment in Men With Metastatic Castrate Resistant Prostate Cancer — Completed
• Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy — Completed
• Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects — Completed
• Efficacy Study of ABR-215050 to Treat Prostate Cancer — Completed
• TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer — Completed